Spontaneous HCV clearance in HCV/HIV-1 coinfection associated with normalized CD4 counts, low level of chronic immune activation and high level of T cell function

Journal of Clinical Virology

Volumn 41, Issue 2, 2008, Pages 160-163

  Falconer, Karolin ^a   Gonzalez, Veronica D ^a   Reichard, Olle ^a   Sandberg, Johan K ^a   Alaeus, Annette ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

HAART; HCV clearance; HCV HIV 1 coinfection; T cell activation; T cell function

Indexed keywords

DIDANOSINE; LAMIVUDINE; LAMIVUDINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; STAVUDINE; TENOFOVIR;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CD4 LYMPHOCYTE COUNT; CELL FUNCTION; CELLULAR IMMUNITY; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; NONHUMAN; PRIORITY JOURNAL; SCORING SYSTEM; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

CD4 LYMPHOCYTE COUNT; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; MIDDLE AGED; T-LYMPHOCYTES;

EID: 38749083392     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcv.2007.11.005     Document Type: Article

References (12)

1. Aandahl E.M., Quigley M.F., Moretto W.J., Moll M., Gonzalez V.D., Sonnerborg A., et al. Expansion of CD7low and CD7negative CD8 T-cell effector subsets in HIV-1 infection: correlation with antigenic load and reversion by antiretroviral treatment. Blood 104 (2004) 3672-3678
2. Betts M.R., Nason M.C., West S.M., De Rosa S.C., Migueles S.A., Abraham J., et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood 107 (2006) 4781-4789
3. Bica I., McGovern B., Dhar R., Stone D., McGowan K., Scheib R., et al. Increasing mortality due to end-stage liver disease in patients with human immunodeficiency virus infection. Clin Infect Dis 32 (2001) 492-497
4. De Rosa F.G., Audagnotto S., Bargiacchi O., Garazzino S., Marucco D.A., Veronese L., et al. Resolution of HCV infection after highly active antiretroviral therapy in a HIV-HCV coinfected patient. J Infect 53 (2006) 215-218
5. Deeks S.G., Kitchen C.M., Liu L., Guo H., Gascon R., Narvaez A.B., et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104 (2004) 942-947
6. Giorgi J.V., Hultin L.E., McKeating J.A., Johnson T.D., Owens B., Jacobson L.P., et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 179 (1999) 859-870
7. Graham C.S., Baden L.R., Yu E., Mrus J.M., Carnie J., Heeren T., et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis 33 (2001) 562-569
8. Hazenberg M.D., Otto S.A., van Benthem B.H., Roos M.T., Coutinho R.A., Lange J.M., et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. Aids 17 (2003) 1881-1888
9. Koziel M.J., and Peters M.G. Viral hepatitis in HIV infection. New Engl J Med 356 (2007) 1445-1454
10. Lauer G.M., Nguyen T.N., Day C.L., Robbins G.K., Flynn T., McGowan K., et al. Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses. J Virol 76 (2002) 2817-2826
11. Mocroft A., Bofill M., Lipman M., Medina E., Borthwick N., Timms A., et al. CD8+, CD38+ lymphocyte percent: a useful immunological marker for monitoring HIV-1-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol 14 (1997) 158-162
12. Zeitoun J.D., Mallet V., Chaix M.L., Viard J.P., Blanche S., and Pol S. Stable recovery from HCV in HIV-HCV co-infection under antiretroviral therapy. J Clin Virol 40 (2007) 71-73